Navigation Links
Analysis of Ulcerative Colitis (UC) Time to Symptom Resolution Data from Pivotal Study of LIALDA(TM) (mesalamine) Presented at DDW
Date:5/20/2008

SAN DIEGO, May 20 /PRNewswire-FirstCall/ -- A post hoc analysis showing time to symptom resolution data from a study (study 302) of Shire plc's (LSE: SHP, Nasdaq: SHPGY) ulcerative colitis (UC) drug, LIALDA(TM), will be presented today at Digestive Disease Week (DDW). Study 302 (further referred to as "Kamm study," led by Dr Michael A. Kamm, from St Mark's Hospital in London, UK), demonstrated LIALDA was effective in inducing remission in patients with active, mild to moderate ulcerative colitis compared to placebo and these study results were published in the January 2007 issue of Gastroenterology.

"The time between initiation of therapy and initial symptom resolution is an important endpoint in the treatment of UC for both patients and physicians," said Gary Lichtenstein, director of the Inflammatory Bowel Disease Program at the University of Pennsylvania, investigator on this post hoc analysis. "This analysis was important as it showed LIALDA benefits patients by significantly lowering the time it takes patients to experience relief from their UC symptoms as compared to placebo."

Time to initial symptom resolution on LIALDA

Poster Presentation: May 20, 2008, San Diego Convention Center -- Sails Pavilion, #T1140

A post hoc analysis of the Kamm study (study 302) examined the treatment time required for patients to experience initial symptom resolution over eight weeks. In this analysis, time to initial symptom resolution was assessed as either the time between the first dose of study medication and the first day of symptom resolution (rectal bleeding or normalization of stool frequency or both) or the time between the first dose of study medication and the first day of three consecutive days of symptom resolution. Initial symptom resolution of rectal bleeding, normalization of stool frequency or both was assessed by a modified UC-Disease Activity Index (UC-DAI) scoring system. Resolution of symptoms was defined for both rectal ble
'/>"/>

SOURCE Shire plc
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis
2. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
3. New Data From Large Safety Analysis of MYCAMINE Shows Favorable Clinical Safety Profile
4. Immtech Announces Interim Analysis in Phase III African Sleeping Sickness Trial
5. Analysis Shows Vernakalant Hydrochloride Injection Increases Conversion to Normal Heart Rhythm in Acute Atrial Fibrillation Patients Treated Within 48 Hours of Onset
6. New Analysis of Study Data Shows That Asacol(R) (Mesalamine) Delivers Rapid Symptom Relief for Ulcerative Colitis Patients
7. A Sociolinguistic Analysis of In-Office Dialogue Reveals Psychiatrists and Parents Have Significantly Different Perceptions on ADHD and Psychiatric Comorbidities
8. Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results
9. Results Of VYVANSE(TM) (lisdexamfetamine dimesylate) Effect Size Analysis Presented at Major Scientific Meeting
10. Progen Presents Additional Analysis of Data from PI-88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases
11. Retrospective Analysis Finds That Initiation of Insulin Glargine in Patients With Type 2 Diabetes was Associated With a Lower Incidence Rate of Myocardial Infarction as Compared With NPH Insulin

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...INVIEW,Calif.,Nov.25/PRNewswire/-- ChemoCentryx,I...heCompany,sPROTECT-1(theProspectiveRandomizedOralT...N(TM)(CCX282-B)inpatientswithmoderate-to-severeCro...blesafetyandtolerabilityprofile.Thestudydemonstrat...eseverityasdefinedasa70-pointdecreaseintheCrohn,sD...
(Date:11/24/2009)...,Calif.,Nov.24/PRNewswire-FirstCall/--Endologix,In...tmentsforaorticdisorders,announcedtodaythatithasfi...patentinfringementlawsuitbroughtagainstitinOctober...istrictCourtinIndianapolis,Indiana. ,, Endologi...edStatesPatentandTrademarkOffice(USPTO)conductspro...
(Date:11/24/2009)...GO,Nov.24/PRNewswire-FirstCall/--AnadysPharmaceuti...esentatthe21stAnnualPiperJaffrayHealthcareConferen...T).TheconferenceisbeingheldatTheNewYorkPalaceHotel...cerofAnadys,willprovideanoverviewofAnadysanditscli...ecorporatepresentationwillbesimultaneouslywebcasta...
Breaking Medicine Technology:ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference 2Stereotaxis Reports 26 25 Third Quarter 2009 Revenue Growth 60749 1Stereotaxis Reports 26 25 Third Quarter 2009 Revenue Growth 60749 2Stereotaxis Reports 26 25 Third Quarter 2009 Revenue Growth 60749 3Stereotaxis Reports 26 25 Third Quarter 2009 Revenue Growth 60749 4Stereotaxis Reports 26 25 Third Quarter 2009 Revenue Growth 60749 5Stereotaxis Reports 26 25 Third Quarter 2009 Revenue Growth 60749 6Stereotaxis Reports 26 25 Third Quarter 2009 Revenue Growth 60749 7Stereotaxis Reports 26 25 Third Quarter 2009 Revenue Growth 60749 8Oso Healthcare Provides Implementation and Support Services for ClearCanvas Open Source RIS PACS 60748 1Oso Healthcare Provides Implementation and Support Services for ClearCanvas Open Source RIS PACS 60748 2Oso Healthcare Provides Implementation and Support Services for ClearCanvas Open Source RIS PACS 60748 3Oso Healthcare Provides Implementation and Support Services for ClearCanvas Open Source RIS PACS 60748 4Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 14730 1Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 14730 2Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 14730 3Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 14730 4Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 14730 5Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 14730 6Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 14730 7Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 14730 8Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 14730 9
...0 Genetic Variants Are Associated,With Adult Onset...In the most,comprehensive look at genetic risk fac...eam, working in close collaboration with two,other...variants,associated with increased risk of diabete...ings of the three groups, published,simultaneously...
...a, spinal cord and other central,nervous system tr...wire/ -- Scientists at the,Schepens Eye Research I...have identified a key mechanism for successfully,t... system. The,study found that a molecule known as ...lity to break down barriers on the outer,surface o...
Other Medicine Technology:Researchers Identify New Genetic Risk Factors for Type 2 Diabetes 2Researchers Identify New Genetic Risk Factors for Type 2 Diabetes 3Researchers Identify New Genetic Risk Factors for Type 2 Diabetes 4Researchers Identify New Genetic Risk Factors for Type 2 Diabetes 5Researchers Identify New Genetic Risk Factors for Type 2 Diabetes 6Researchers Identify New Genetic Risk Factors for Type 2 Diabetes 7Schepens Scientists Identify Key to Integrating Transplanted Nerve,Cells Into Injured Tissue 2Schepens Scientists Identify Key to Integrating Transplanted Nerve,Cells Into Injured Tissue 3
(Date:11/25/2009)...urvivors often plagued by neurological symptoms, s...thDay News) -- Neurological side effects are among...rs of testicular cancer who were treated with cisp..., The study included 1,409 Norwegian men treated... 1994 who took part in a follow-up survey conducte...
(Date:11/25/2009)..., ARLINGTON,Va.,Nov.25/PRNewswire-USNewswire/...PreventHealthCareFraudActof2009,"S.2128,whichisdes...bletopreventfraudinMedicare.Thebillwasintroducedby...tainsseveralprovisionstheAmericanAssociationforHom...chtheAssociationproposedtoCongressinFebruary.Those...
(Date:11/25/2009)... A drug used to treat colorectal cancer also can r...dered first-line therapy for the disease, research... this week. , Mntrier,s disease causes thickening...sea and vomiting, as well as anemia and swelling i...s are at increased risk for gastric cancer. Previo...
(Date:11/25/2009)...tudy found puffs of air on flesh that mimicked par... , WEDNESDAY, Nov. 25 (HealthDay News) -- Peopl...th their skin, new research shows. , In fact, s...pes of speech actually helped people decipher soun... have never been able to show whether we could use...
(Date:11/25/2009)... BioSpace.com, the premier..., unveiled the third edition of the BioForest&trad... Englewood, CO (Vocus) November 25, 2009 ...ence careers and information, unveiled the third e...s morning., , , , ,This regional campaign is a pr...
Breaking Medicine News(10 mins):Health News:American Association for Homecare Endorses New U.S. Senate Bill, the 'Prevent Health Care Fraud Act of 2009' 2Health News:Vanderbilt scientists report first effective medical therapy for rare stomach disorder 2Health News:Your Skin Can Help Your Ears Listen 2Health News:Your Skin Can Help Your Ears Listen 3Health News:BioSpace Showcases Leading Life-Science Companies in the Northwest 2
...ne named Bik can shrink or kill tumors in the panc...shed Monday, offering hope for one of the deadlies...expresses a protein that forces cancer cells to ki...DD, which spares healthy tissue. "There ar...
...Optical, Inc. announced the release of its Eyeglas...mers in making educated choices hen selecting thei...re professionals across the country, this resource...on. Eyeglassguide offers information about ...
...e passed a break through energy bill. The bill pro... time in 20 years and fund research n alternative ...easures to soothe growing public concern over risi... recommended pushing back deadlines for the transi...
...h Prime Minister Michel Rocard, who underwent emer...s discharged from hospital here on Tuesday. ...ck his total memory and he is discharged from the ...ll ill minutes before attending an event organised...
...xican cuisine, which is one of the world's tasties... say scientists at the Smithsonian Institution . ...Museum of Natural History says that as early as 1,... in the Proceedings of the National Academy of Sci...
...at the University of Texas M. D. Anderson Cancer C...ecularly engineered therapy selectively embeds a ...es tumours, inhibits metastasis, and prolongs surv...r therapy and perhaps for imaging," notes senior a...
Other Medicine News:Health News:Mutated Gene Zaps Pancreas Cancer in Mice 2Health News:Eyeglass Guide Launched That Aids in Choosing the Right Eyewear 2Health News:A Break Through Energy Bill by the US Government 2Health News:A Break Through Energy Bill by the US Government 3Health News:Spicy Cuisine Originated in Mexico 1,500 Years Ago 2Health News:Gene Therapy Eradicates Pancreatic Cancer in Mice 2
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
Medicine Products: